Two Bear Capital

We’re proud to announce our participation in a pioneering European project led by the Medical University of Vienna to develop a next-generation #vaccine against #influenza. For the initiative, Inimmune will provide its proprietary intranasal vaccine adjuvant INI-4001, which has capability to enhance vaccine efficacy and provide broader and longer-lasting protection against seasonal influenza strains and strains with pandemic potential. The consortium has submitted its proposal to European Health and Digital Executive Agency (HaDEA) and is seeking to be selected under the European Commission’s #EU4Health program. Read more here: https://lnkd.in/eghaGUaC

Great news today! Revenium announced the closing of $13.5 million in Seed round funding led by Two Bear Capital with continued support from WestWave Capital. Providing the solutions today’s businesses need, Revenium turns AI usage into ROI clarity by cutting costs, boosting margins, and giving leaders real-time visibility across models and agents. We are so excited about the potential of this company and its ability to provide real insight into how operations use AI. We are also grateful for the opportunity to work with the entire team at Revenium led by John Rowell, @John D’Emic, Jason Cumberland, and Bailey Caldwell. Great things to come! 𝐑𝐞𝐚𝐝 𝐭𝐡𝐞 𝐩𝐫𝐞𝐬𝐬 𝐫𝐞𝐥𝐞𝐚𝐬𝐞: https://lnkd.in/eUsDi3zn 𝐂𝐡𝐞𝐜𝐤 𝐨𝐮𝐭 𝐑𝐞𝐯𝐞𝐧𝐢𝐮𝐦 𝐢𝐧 𝐭𝐡𝐞 𝐓𝐁𝐂 𝐏𝐨𝐫𝐭𝐟𝐨𝐥𝐢𝐨: https://lnkd.in/emj8szf9 𝐅𝐨𝐫 𝐦𝐨𝐫𝐞 𝐯𝐢𝐬𝐢𝐭: www.revenium.ai #AIeconomics #FinOps #APIMonetization #Revenium #TwoBearCapital

We’re excited to announce a strategic collaboration with NuvOx Therapeutics to support their Phase 2b #glioblastoma trial, funded by a grant from the National Cancer Institute (NCI).     Under the award, FYR will apply its EV-Omics™ (EVO) platform and SPARCs™ enrichment technology to longitudinal blood samples collected in NuvOx’s RESTORE trial of NanO₂™, a radiosensitizer designed to reverse tumor hypoxia. The collaboration will explore extracellular-vesicle biomarkers that reflect hypoxia biology, correlate with treatment exposure, and help clinicians differentiate pseudoprogression from true progression—a persistent challenge in glioblastoma management.     We’re proud to contribute to this important effort alongside NuvOx and look forward to advancing meaningful outcomes for patients impacted by glioblastoma. Read full press release here: https://lnkd.in/gW2VNnye   📌 Interested in learning more about our EV‑Omics technology or exploring how liquid biopsies can enhance your clinical trial program? Contact us at bd@fyr.bio.  

This week, we’re headed to the 2025 Society for Neuro-Oncology Annual Meeting!    The FYR team is excited to connect with the #NeuroOncology community and share our latest work exploring the proteomic fingerprints of malignant #glioma.     📌 Poster: Sex-associated Biomarker Signatures in Malignant Glioma: Insights from a Proteomics Study   🗓 Nov. 22, 11:45 a.m. - 1:05 p.m. HST  📍 Kamehameha Exhibit Hall II & III, Hawaii Convention Center    If you’ll be at #SNO2025, stop by to learn how protein-based insights may help reveal new ways to understand and treat this challenging disease.     Learn more:  https://lnkd.in/dfQ5zdzp    #PrecisionMedicine #Biomarkers #BrainTumorResearch #Glioblastoma 

SC25 is almost here! We’re bringing two full days of technical deep dives, live demos, and expert Q&As to Booth 736, covering the full HPC stack from AI workload orchestration to enterprise hardening. On November 18-19, our in-booth programming features sessions with the companies powering enterprise HPC and AI infrastructure: - Sandia National Labs (Tuesday, 12:00 PM): Real-world Fuzzball deployment at scale - AMD (Tuesday, 1:30 PM and Wednesday, 2:00 PM): Rocky Linux + Warewulf Pro hardware integration - Google Cloud (Tuesday, 2:30-3:30 PM): RL9 roadmap, deprecation timelines, and GCP acceleration - NVIDIA (Wednesday, 11:00 AM): Q&A with Greg Kurtzer on GPU workload optimization Check out our full event schedule (with 15+ sessions) here: https://lnkd.in/e2uSHXMa #SC25 #HPC #hpcignites

Big news at QuSecure We’re proud to welcome Garfield Jones, D.Eng. as our new Senior Vice President of Research & Technology Strategy. Dr. Jones joins us from the U.S. Cybersecurity and Infrastructure Security Agency (CISA), where he served as Associate Chief of Strategic Technology. He led CISA’s Post-Quantum Cryptography (PQC) initiative and helped shape national policy on quantum security in collaboration with the White House, OMB, and ONCD. His leadership and expertise will play a pivotal role in advancing QuSecure’s mission to deliver post-quantum resilience across government and enterprise. Welcome to the team, Dr. Jones — we’re honored to have you on board! https://lnkd.in/e8GYzh4U #Cybersecurity #PostQuantum #QuantumSecurity #QuSecure #Leadership

📣 Fresh off the Press: Gina AI, Graphiant's Intelligent Network Assistant, Press Release is out now 📣 "As part of our AI journey, we wanted something more than just a chat tool. We built an agent who is your day-to-day partner enforcing your AI data strategy," said Ali Shaikh, CEO of Graphiant. "Gina brings policy, evidence, and outcomes together, and with her help, teams move faster and stay aligned with governance." 👉 Watch the demo live in action today at Tech Field Day on their LinkedIn or on the #NFD39 website: https://hubs.ly/Q03RQ1mC0